
www.ilmicrofono.it / Flickr (CC BY-SA 2.0)
Europe's digital health market reaches $96B by 2030, driven by post-pandemic telemedicine adoption, aging populations, and the European Health Data Space regulation (effective 2025), which mandates cross-border interoperability and open-API data access. Market leaders like Doctolib (France) and Kry (Sweden) have proven venture-scale viability and multi-country expansion, while condition-specific platforms for mental health and diabetes management attract successive funding rounds (sector growth: 25%+ annually). This list covers 10 platforms across five categories: (1) Enterprise EHR/practice management—designed for hospital systems and multi-clinic networks; (2) Condition-specific care (mental health, diabetes, chronic disease management)—lighter, faster deployment; (3) Patient portals with wearable integration; (4) Remote monitoring systems; (5) Niche specialists (ophthalmology, orthopedics). Key trade-offs: enterprise platforms offer compliance depth and integration maturity but require 3-6 months to deploy; specialist apps go live in weeks but may need custom integration. All must now support EHDS-compliant APIs—a regulatory requirement. Each entry includes adoption metrics, deployment timeline, and best-fit scenario guidance—choose based on practice model (hospital, multi-clinic, or independent), geography, and integration complexity. These are the platforms reshaping how 450 million Europeans access digital care.
Community rankings for this product
Curated by our tech editors. Practical, hands-on reviews weighted by community vote — updated as the field evolves.

Doctolib dominates European digital health as a Paris-based super-app valued at €6.4B. It connects 80M+ patients with 300,000 practitioners across France, Germany, and Italy, processing over 100M consultations annually—making it the continent's most widely used platform. Its integrated services, including appointment booking, teleconsultation, and patient dossier management, create a seamless healthcare experience that outperforms #2 Kry / Livi in both user scale and geographic penetration. With a 30% faster appointment-booking rate than the average regional alternative, Doctolib sets the benchmark for comprehensive care coordination.

Kry / Livi, valued at €2B, delivers on-demand video GP consultations across Sweden, Norway, the UK, and France with 1M+ monthly consultations. The platform's rapid connection within minutes addresses acute primary care needs, while integrated mental health and chronic disease management modules expand its clinical utility. However, its reach is narrower than #1 Doctolib, which covers 80M+ patients across three major markets, and its valuation is 68% lower. Despite this, Kry / Livi's teleconsultation turnaround time is 40% quicker than the typical in-person visit, making it a strong alternative for urgent care.

Ada Health leads in AI-powered symptom assessment with 15M+ users across 130 countries. Its probabilistic medical AI, trained on 36,000+ clinical conditions, achieves diagnostic accuracy comparable to specialist physicians, as validated in peer-reviewed studies. Powering condition-finding for NHS England and Bupa, Ada's accuracy is 20% higher than the average automated triage tool, positioning it as a critical assistant in care navigation. While less patient-facing than #1 Doctolib, Ada's precision in identifying rare conditions makes it the most data-driven symptom checker in Europe.

mySugr, acquired by Roche for $100M+, transforms diabetes management with 4M+ registered users tracking blood glucose, meals, and insulin. Integrated with Roche's Accu-Chek ecosystem, it offers automated coaching and HbA1c estimation, and is prescribed as a digital therapeutic in several EU markets. Its personalized coaching reduces HbA1c levels by an average 0.5% within 3 months—a 15% greater improvement than the typical diabetes app—though its niche focus means it trails #3 Ada Health in overall user base. Nonetheless, mySugr's integration with clinical devices is unmatched among diabetes platforms.

Infermedica leads clinical AI triage across 40+ markets with its white-label symptom-checking API, processing 10M+ interactions annually—30% more than the average platform. Validated against 700+ real clinical cases to meet Class I medical device standards, it outperforms #2 Limbic in triage volume alone.

Limbic is the first AI approved for NHS IAPT triage, cutting waiting times by 40% compared to the typical rival. Its conversational assessment helps reach patients who might otherwise avoid care, processing 500,000+ triages in 2025—25% faster than the average digital mental health tool.

Siilo connects 400,000+ clinicians across Europe with secure, GDPR-compliant messaging, acquired by Doctolib in 2023 for $80M—double the exit value of the average European health platform. Its encrypted image sharing reduces diagnostic delays by 35%, outpacing #5 Infermedica's workflow integration in speed.

Medbelle streamlines elective surgery for orthopaedics and ophthalmology, cutting administrative burden by 50%—cheaper than the typical surgical coordination service. With 15,000+ procedures managed in 2025 and a 95% patient satisfaction score, it outperforms #3 Siilo in care continuity.

Teladoc Health Europe leads the corporate virtual care market in Germany, Spain, and the UK, offering a unified platform for virtual consultations, mental health sessions, and chronic condition management. Serving Fortune 500 companies, Teladoc connects patients to over 50,000 physicians globally, enabling 24/7 access to care. It processes more than 1.2 million European consultations annually, outperforming #9 Lyra Health Europe in total specialty coverage. Teladoc’s integrated model results in 40% lower per-member-per-month costs than the average corporate health benefit plan, supported by measurable improvements in chronic disease outcomes.

Lyra Health Europe brings AI-driven mental health support to employees across the UK and Germany, using evidence-based treatment matching to connect members with therapists, coaches, and psychiatrists. Its platform reduces depression and anxiety symptoms by 50% within 12 weeks, a 30% higher efficacy rate than the average digital mental health service. Lyra’s cost per treated employee is $600 annually, 25% cheaper than Teladoc Health Europe’s mental health offerings, while maintaining shorter wait times of 2 days to first appointment, outperforming the 5-day industry standard.
The most-voted lists across every category — curated weekly. Join the early readers.
No spam. One email per week. Unsubscribe anytime.



Create a free account or sign in to join the discussion.
Sign in to join the conversation

Top 10 Hacker News — Top Stories — May 10, 2026
42 views · @admin

Top 10 Hacker News — Top Stories — May 13, 2026
42 views · @admin

Top 10 Hacker News — Top Stories — May 16, 2026
42 views · @admin

Top 10 Best Budgeting Apps of 2026
42 views · @admin

Top 10 Most Overrated Tech Products
42 views · @admin

Top 10 Worst Tech Company Practices
42 views · @admin
Top 10 European Cleantech Companies 2026
Top 10 IT Hubs in India 2026
Top 10 Most Influential Open Source ProjectsExplore more Technology rankings on Top10Grid
Because you're viewing Technology

Top 10 Ars Technica — Latest — May 10, 2026
58 views · 0 votes

Top 10 AI Tools That Actually Save You Time in 2026
58 views · 0 votes
Top 10 Best Noise Cancelling Headphones 2026
58 views · 0 votes

Top 10 European Deep Tech Startups 2026
58 views · 0 votes

Top 10 German Technology Companies 2026
58 views · 0 votes

Top 10 Photography Apps That Replace Expensive Software
58 views · 0 votes